Recent Posts

Blog, Patient Advocacy, RareDiseases
The Impact of NHS Genomics Medicine Service on Rare Disease
Posted 22nd February 2022

The Impact of NHS Genomics Medicine Service on Rare Disease

Read More
Blog , Patient Advocacy , RareDiseases
Hopes for the future of Precision Medicine
Posted 21st February 2022

Hopes for the future of Precision Medicine

Read More
Blog , EVENT , AI
Congenica AI at Festival of Genomics
Posted 15th February 2022

Congenica AI at Festival of Genomics

Read More
Blog
Celebrating Congenica
Posted 11th February 2022

Celebrating Congenica's Women in Science

Read More
Blog , Product , AI
Congenica 3.3 improves genomic data analysis and automates workflow
Posted 1st February 2022

Congenica 3.3 improves genomic data analysis and automates workflow

Read More
Blog , Patient Advocacy , genomics
Global barriers to genomics - Malaysian Epilepsy Conference
Posted 28th January 2022

Global barriers to genomics - Malaysian Epilepsy Conference

Read More
News , partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted 27th January 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted 24th January 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
Blog , Patient Advocacy , RareDiseases
Added fear of mortality for rare caregivers
Posted 18th January 2022

Added fear of mortality for rare caregivers

Read More
News
Congenica Expands its Clinical Consulting Services
Posted 13th January 2022

Congenica Expands its Clinical Consulting Services

Read More
Blog , EGM2021 , on-demand webinar
Enabling Genomic Medicine in China
Posted 6th January 2022

Enabling Genomic Medicine in China

Read More
previous
1 2 3 4 5
... 22 next
Blog , Patient Advocacy , RareDiseases
The Impact of NHS Genomics Medicine Service on Rare Disease
Posted 22nd February 2022

The Impact of NHS Genomics Medicine Service on Rare Disease

Read More
Blog , Patient Advocacy , RareDiseases
Hopes for the future of Precision Medicine
Posted February Feb 21st 2022

Hopes for the future of Precision Medicine

Read More
Blog , EVENT , AI
Congenica AI at Festival of Genomics
Posted February Feb 15th 2022

Congenica AI at Festival of Genomics

Read More
Blog
Celebrating Congenica
Posted February Feb 11th 2022

Celebrating Congenica's Women in Science

Read More
Blog , Product , AI
Congenica 3.3 improves genomic data analysis and automates workflow
Posted February Feb 1st 2022

Congenica 3.3 improves genomic data analysis and automates workflow

Read More
Blog , Patient Advocacy , genomics
Global barriers to genomics - Malaysian Epilepsy Conference
Posted January Jan 28th 2022

Global barriers to genomics - Malaysian Epilepsy Conference

Read More
News , partners
Congenica and IAB Agree to Distribution Deal in Central Europe
Posted January Jan 27th 2022

Congenica and IAB Agree to Distribution Deal in Central Europe

Read More
News
Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 
Posted January Jan 24th 2022

Congenica launches Comprehensive Genetic Carrier Screening at Arab Health 2022 

Read More
Blog , Patient Advocacy , RareDiseases
Added fear of mortality for rare caregivers
Posted January Jan 18th 2022

Added fear of mortality for rare caregivers

Read More
News
Congenica Expands its Clinical Consulting Services
Posted January Jan 13th 2022

Congenica Expands its Clinical Consulting Services

Read More
Blog , EGM2021 , on-demand webinar
Enabling Genomic Medicine in China
Posted January Jan 6th 2022

Enabling Genomic Medicine in China

Read More
previous
1 2 3 4 5
... 22 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.